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ABSTRACT
The World Health Organization reports that approximately 80% population from developing countries are facing complications from synthetic drugs 
used in maintaining their primary health-care needs. The chemotherapeutic strategies are very striking and have earned serious concern as potential 
means of controlling the incidence of this dreadful disease. However, the major problem in cancer is the long lasting toxicity of the well reputable 
chemical drugs. Since ancient times, medicinal plants have attracted enormous attention, to fight against various diseases with their broad-spectrum 
biological and therapeutic properties. Although plants, phytochemicals and their analogues have been confirmed to be safe and effective, having 
strong anticancer properties. A number of pharmaceutical agents with diverse chemical structures of natural origin from plants have been discovered 
as anticancer agents such as vincristine, vinblastine, podophyllotoxin, camptothecin, taxol, resveratrol, withaferin A, quercetin, and curcumin. Further 
modifications of these phytochemicals led to the development of numerous outstanding molecules such as drugs like topotecan, irinotecan, taxotere, 
etoposide, and teniposide. In this in-depth review, we meticulously investigated the selected medicinal plants for their anticancer properties. In 
particular, novel compounds from plants have beneficial effects on human health. Our observations suggest the preventive and therapeutic use of 
phytochemicals in managing various human malignancies.
Keywords: Natural products, Anticancer drugs, Alkaloids, Podophyllotoxin, Camptothecin, Resveratrol, Curcumin, Quercetin etc., Cell cycle arrest, 
Apoptosis.
INTRODUCTION
Over two decades ago, Hippocrates, the founder of medicine, described 
about 400 medicinal plants and advised “let food be your medicine and let 
medicine be your food [1].” Herbal plants continuously play a vital role in 
the health-care system throughout the world’s population. In developing 
countries, folk medicines are essential part and have a long and 
everlasting history because of low cost, easy availability, tribal familiarity, 
and skilled/experienced all over the world [2]. Since ancient times, a 
huge number of modern drugs have been isolated from plants in whole, 
and its chemical compounds (photochemicals) are used as medicines in 
Asian and Greek countries [3]. Today’s major scientific and technological 
processes in combinatorial chemistry and the remedies obtained from 
natural sources make an increased contribution to drug discovery. Some 
of the therapeutic drugs from natural sources are enlisted in Table 1, 
obtained from natural sources such as plants, microbes, and marine 
organisms with their therapeutic uses as well as modes of action [4-6].
CANCER
Cancer is a life-threatening, dreadful disease, growing health problem 
in developing as well as developed countries. It is regarded to be more 
of a developed world issue. All cancers except non-melanoma skin 
cancer are 1.8 times more in highly developed countries compared with 
less developed [7]. A recent report by the World Health Organization 
(WHO) 2014, about 6.2 million people were died due to cancer. It has 
also been expected that the number of annual cases of cancer enhances 
from 14 million in 2012 to 22 million within the next two millennia 
[8]. This disease is categorized by proliferation of cells abnormally, by 
which other cells/tissues are damaged which lies adjacent to these cells 
resulted in the destruction of them [9].
Several approaches of herbal drugs having the potency to improve 
immune cells of the body against cancer have been made. Thus, based 
on the detailed reported and complex synergetic combinations of 
various phytochemicals with anticancer potential, a large number 
of herbal remedies have been designed to fight against cancer cells 
without damaging healthy cells of the body [10,11]. Plants have played a 
significant role as a source of valuable anticancer agents, and in one way 
or another, it is accepted that over 60% currently used anticancer agents 
are derived from natural sources, including plants, marine organisms, 
and microorganisms (Table 1) [12,13]. Because of the adverse or lethal 
side effects of chemotherapy, radiation therapy and due to the growing 
rate of mortality associated with cancer, new anticancer agents have 
been derived from nature. In the early 1950s, selection of medicinal 
plants as a source of anticancer agents was started, with the discovery 
and development of vinca alkaloids (vinblastine [VLB] and vincristine 
[VCR]) and the isolation of the cytotoxic podophyllotoxins [14].
CANCER-CAUSING GENES AND THEIR ACTION
Mainly four types of genes are involved in cell division. Most tumors 
have damaged copies of more than one of the genes as follows:
i. Oncogenes (OG)
 Oncogenes have the potential to cause cancer. These genes play an 
important role in the cells to start dividing under normal conditions. 
Growth rate of cells increases on activation of such genes. Cancer 
develops when one of these genes get damaged, and it works like 
accelerator becoming jammed down the cell with all daughter cells 
and are permanently instructed to divide [15].
ii. Tumor suppressor genes (TSG)
 It is also known as antioncogenes. These genes were codiscovered by 
David Lane in 1979(UK). Proteins are made, which function normally 
but opposite to that of ontogenesis with the help of TSG. One of the 
most important TSGs is p53 [15].
iii. Suicide genes (SG)
 Suicide gene is a gene which causes a cell to kill itself through 
apoptosis. Apoptosis or cell suicide is treated to be a more complex 
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and extremely important process. To prevent harm to the neighboring 
cells usually, cells have the ability to commit suicide when something 
goes wrong. A number of SG are involved in cancer diseases. When 
the “SGs” get damaged, a faulty cell can protect dividing and become 
cancerous [15]. Cells usually have the ability to commit suicide 
whenever something goes wrong, to prevent damage to their 
neighbors. There are many different genes involved. If the “SGs” 
become damaged, then a faulty cell can keep dividing and become 
cancerous.
iv. DNA repair genes (DRG)
 Since DNA is present in every cell of the body, which is continuously 
attacked from a variety of directions, cells contain different kinds of 
proteins whose work is to repair the damaged DNA [15].
PLANT-DERIVED ANTICANCER AGENTS IN CLINICAL USE
Anticancer drugs or anticancer agents can prevent or inhibit the 
maturation and proliferation of cancer cells. These agents travel to 
different parts of the body and devastate the cancerous cells. These 
drugs can also be used significantly in combination with radiotherapy, 
surgery, and immunotherapy in the united modality approach for many 
solid tumors particularly metastasis. 
Vinca alkaloids
The vinca alkaloids are the first carriers to advance into clinical use 
against cancer in the form of bisindole alkaloids such as VLB and VCR 
(Fig. 1a) isolated from the rain forests of Madagascar periwinkle plant, 
Catharanthus roseus G. Don. (Apocynaceae) [14]. The mechanism of 
action of vinca alkaloids is that, as they interact with tubulin, mitotic 
spindle assembly disrupts. Particularly, when the vinca alkaloids 
specifically bind to β-tubulin, as a result they block the capability of 
α-tubulin to polymerize into microtubules. This directs to the killing 
of actively dividing cells by inhibiting progression during mitosis [16]. 
Recent studies show that vinorelbine (VRLB) and vindesine are the 
two semi-synthetic analogs obtained from these agents (VLB and VCR). 
Primarily in combination with other cancer chemotherapeutic drugs, 
VLB and VCR are used for the treatment of various cancers, including 
lymphomas, leukemias, testicular cancer, breast and lung cancers, and 
Kaposi’s sarcoma [14].
Another bifluorinated, semi-synthetic tubulin-targeted vinca alkaloid 
called vinflunine (Fig. 1b) is collected when the two fluorine atoms are 
introduced into VRLB molecule. It shows similar properties like other 
vinca alkaloids in mitotic-arresting and tubulin-interaction activities, 
but due to lesser neurotoxicity, microtubules involved in axonal 
transport show weak compatibility than those involved in mitosis. In 
in vivo preclinical studies, it has been identified that vinflunine is having 
marked and superior antitumoral activity than that of VLB against a 
large number of tumor models. In combination with other chemical 
drugs such as cisplatin, mitomycin C, doxorubicin, and 5-fluorouracil, 
vinflunine showed synergism [17].
Podophyllotoxin
Podophyllotoxin (Fig. 2a) is a renowned substance due to its precious 
anticancer activities and well-known use in chemotherapy, in 
pharmaceutical industry. The chief plant source of this compound is 
Podophyllum emodi, which is categorized as an endangered species 
due to over exploitation [18]. Besides, the second most frequently used 
source is Podophyllum peltatum, which produces only one-third part of 
the podophyllotoxin than that of P. emodi [19].
The main molecular mechanism of podophyllotoxin responsible 
for the anticancer activity is to prevent the assembly of tubulin into 
microtubules which induce apoptosis. Different in vitro experimental 
examinations showed the effect on microtubule assembly by the 
interaction of podophyllotoxin with tubulin. However, the fact was 
that podophyllotoxin hinders the formation of the mitotic spindle 
microtubules by preventing the polymerization of tubulin which induces 
Table 1: Therapeutic drugs from natural sources
Drugs Medicinal use Mode of action Source
Aspirin Analgesic, inflammatory, antipyretic Anti-inhibition of COX (cyclooxygenase) Plant
Atropine Pupil dilator Antagonist of Ach (acetylcholine) at muscarinic receptors at 
post- ganglionic parasympathetic neuroeffector sites
Plant
Morphine Analgesic Opioid receptor agonist Plant
Digoxin For atrial fibrillation and CHF 
 (congestive heart failure)
Inhibition of the Na+K + ATPase membrane pump Plant
Taxol Anticancer agent Antimitotic agent (binds to and stabilizes microtubules) Plant
Eugenol Toothache Reduces excitability of sensory nerves increases K+efflux and 
reduced Ca2+influx
Plant
Quinine Anti-malarial Prophylaxis inhibition of protein synthesis in the malaria parasite Plant
Caffeine Stimulant Adenosine receptor antagonist Plant
Cyclosporine A Immunosuppressant Inhibition of clonal proliferation of T lymphocytes (through 
inhibition of microbe-lymphokine production)
Microbe
Tetracycline Antibiotic Inhibition of protein synthesis by binding to the ribosome 30S 
subunit
Microbe
Manoalide Anti-inflammatory, analgesic Inhibition of phospholipase A2 Marine organism
Spongistatin 1 Antifungal Inhibition of tubulin polymerization Marine organism
Fig. 1: (a) Vinblastine; R=CH3, vincristine; R=CHO and (b) vinflunine
a b
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cell cycle arrest at mitosis. To mediate anticancer activity, dynamic 
equilibrium gets disturbed between the assembly and disassembly 
of microtubules due to the reversible binding of podophyllotoxin and 
tubulin, which eventually leads to mitotic arrest [20]. A number of 
lignans have been isolated which are closely related to podophyllotoxins, 
used as clinical trials, but due to lack of efficacy and unacceptable 
toxicity, they have to be avoided. After widespread research studies, the 
development of epipodophyllotoxins (an isomer of podophyllotoxin) 
such as etoposide (Fig. 2b) and teniposide (Fig. 2c) has been developed 
as clinically valuable agents and is used in the treatment of bronchial 
and lymphomatic and testicular cancers [14].
In addition, a new podophyllotoxin derivative called podophyllotoxin 
acetate (PA) (Fig. 2d), which was formerly isolated from natural 
product library, used as a drug against cancer and also acts as a 
radiosensitizer [21]. In combination with TOP inhibitor like etoposide, 
PA boosts cell death and its chemosensitizing potential is measured 
to improve the effectiveness of cancer treatment. In other words, 
apoptosis is increased in non-small cell lung cancer cell lines such as 
NCI-H1299 (derived from the lymph node) and A549 (adenocarcinomic 
human alveolar basal epithelial cell) by the interaction of PA and TOP 
inhibitor (etoposide) in synergistic manner through the activation of 
p38 and caspases and inactivation of CREB-1 [22].
Camptothecin (CPT)
CPT (Fig. 3a), a quinoline alkaloid, is an effectual anticancer natural 
product, which has been first isolated from a Chinese plant Camptotheca 
acuminate belonging to the family Nyssaceae. Due to its broad as well as 
very powerful in vitro diversity, it was preferred as a model drug, against 
a broad range of solid tumors including small cell lung carcinoma, 
primary and metastatic colon carcinoma, and stomach, ovarian, breast, 
and pancreatic cancers [24].
On the other hand, CPT revealed ruthless and erratic side effects in 
clinical trials [25], but extensive studies led to the development of CPT 
derivatives in large numbers, and only topotecan (TPT; 9-dimethyl 
amino-10-hydroxy CPT) (Fig. 3b) and irinotecan (CPT-11; 7-ethyl-10-
[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) (Fig. 3c) 
received the Food and Drug Administration (FDA) approval for clinical 
use, in 1996, and were marketed by GlaxoSmithKline and Pharmacia 
(now Pfizer), respectively; at present, they are used for prescription of 
ovarian and colon cancers [26,27].
It is the drug’s ability of CPT analogs to stabilize Top1-DNA cleavage 
complexes (Top1cc) at replication forks, thus leading to collision with 
DNA polymerase and irreversible DNA damage, which induce apoptosis 
that indicates the antitumor activity [28,29].
Taxanes
These are diterpenoid molecules and were first isolated from the plants 
of Taxus genus (Family - Taxaceae). Taxanes include the drugs such as 
paclitaxel (Fig. 4a), docetaxel (Fig. 4b), and cabazitaxel (Fig. 4c). Among 
them, the extraction of paclitaxel was done primarily from the bark of 
Taxus brevifolia [30]. From the past 30 years, such as paclitaxel, no other 
phytochemical has been discovered which attracted the concentration 
of community [31]. Clinically, it is used against many malignancies, while 
others, the semi synthetic analogs such as docetaxel and cabazitaxel are 
ideal for the curing of prostate cancer [32].
As the mitotic inhibitors, taxanes exert the antitumor activity by means 
of several modes of action first and principal mode, and they hinder 
spindle disassembly by the binding of beta- tubulin, thereby stabilizing 
the microtubule spindle, leading to the G2/M cell cycle arrest, in which 
apoptosis is induced, because microtubules are involved in numerous 
cellular processes such as mitosis, cellular transport, cell shape 
maintenance, and cell signalling [32,33].
Homoharringtonine (HHT)
HHT (Fig. 5) is isolated from the evergreen Chinese tree Cephalotaxus 
harringtonia, family Cephalotaxaceae, with clinical applications [34,35]. 
For several decades, this plant alkaloid has been considered as an 
antileukemic agent, mainly in China, and in 2012, ssHHT (omacetaxine 
mepesuccinate), a semi-synthetic form of HHT, has been used for curing 
of chronic myeloid leukemia after approval by the FDA [36]. It exerts its 
antileukemic activities by reducing protein synthesis and inducing cell 
death in a number of leukemia cell lines. This natural compound choked 
Fig. 2: (a) Podophyllotoxin, (b) etoposide, (c) teniposide and (d) podophyllotoxin acetate
Fig. 3: (a) Camptothecin, (b) topotecan, (c) irinotecan
Fig. 4: (a) Paclitaxel, (b) docetaxel, (c) cabazitaxel
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substrates from binding to the receptor site on the ribosome subunit, 
thus damages chain elongation, and hinders protein synthesis [37,38].
SOME OTHER MAJOR PLANT-BASED ANTICANCER AGENTS AND 
THEIR EFFECTS ON CANCER TYPES
Resveratrol
Resveratrol also known as 3, 4, 5ʾ-trihydroxy-trans-stilbene is found 
as a natural polyphenol, in some plants being used as individual’s 
nourishment [39], which is found in Grapes in major quantity [40]. Red 
wines also contain resveratrol in a significant amount [41]. From 1997, 
resveratrol was treated as a cancer chemopreventive mediator as it is 
being active in multiple steps of cancer such as initiation, promotion, 
and progression both in vitro and in vivo, and the development of 
cancer reduced through a number of complementary mechanisms such 
as inhibition of enzymatic activity in both forms of cyclooxygenase 
resulted in the reduction of cancer development [42]. It has also 
been reported that resveratrol could fight against tumor by apoptosis 
and cell cycle arrest. In tumor cell lines, the pro-apoptotic and anti-
proliferative effects of resveratrol have been widely recognized by in 
vitro methods [43].
The effectiveness of this component has been extensively studied on 
colorectal cancer (CRC), as the treatment of 25 µM resveratrol causes 
70% growth inhibition of CaCo-2 cells (the cell of heterogeneous human 
epithelial colorectal adenocarcinoma cells). Tumor incidence of mice 
reduced by giving high doses of resveratrol orally in drinking water 
and diet demonstration [44]. In a concentration- and time-dependent 
manner, resveratrol treatment of 100 µM also repressed the human 
pancreatic cancer cell line proliferation of PANC-1 and AsPC-1, and the 
fraction of sub-G0/G1 cells increased [45].
Withaferin A (WA)
WA is a first purified steroidal lactone, a highly oxygenated 
withanolide, isolated from the plant Withania somnifera, which 
is available as a dietary supplement in the US, and has been used 
for years in Indian Ayurvedic medicine. WA has been identified as 
antitumorigenic in various forms of cancer cells [46], including 
leukemia [47], prostate [48], breast [49], pancreatic [50], and ovarian 
[51]. A number of studies showed that WA exert a large number of 
activities such as it is one of the main biologically active withanolides, 
exerting a large variety of activities, including antitumor, 
radiosensitizing, anti-inflammatory, and cell death inducer and also 
showed antiangiogenic effects [46]. Many biological activities have 
been inclined by WA such as induction of apoptosis through NF-κB 
and Akt inactivation [52], cell cycle arrest at G2/M phase [49], and 
reactive oxygen species generation [53].
Kaempferol
Kaempferol, also known as 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-
4H-1-benzopyran-4-one, is regarded as a natural flavonoid, which is 
found in 80% of many edible plants such as kale, beans, tomato, grapes, 
broccoli, tea, cabbage, leek, endive, and strawberries [54,55]. Extensive 
studies reveal essential mechanisms related to anticancer effects of 
kaempferol in association with apoptosis, cell cycle, inflammation, 
angiogenesis, and reactive oxygen species [56a].
A number of in vitro and in vivo studied of kaempferol showed 
antiproliferative and pro-apoptotic activities against different types 
of cancers such as breast cancer [57], lung cancer [58], prostate 
cancer [59], and kidney cancer [60]. It has been observed in one of the 
studies that kaempferol effectively reduces the proliferation of gastric 
cancer cells, through in vivo and in vitro mitochondrial pathways, 
apoptosis is induced. Cell cycle arrest was also seen at G2/M phase in 
which expression levels of regulating factors such as Cdk1, cyclin B1, 
and Cdc25C this phase also decreased by treating with kaempferol. 
Signalling pathway of ERK1/2 and PI3K/AKT was also reduced by 
kaempferol [61].
One of the studies on cervical cancer has examined that this compound 
suppresses the growth of HeLa cell (cervical cell) as compared to HFF 
cells (normal cells) on the basis of molecular mechanisms. Viability 
of cells was determined by MTT assay, and expression of telomerase 
genes and apoptosis was investigated by real-time polymeric chain 
reaction (PCR) after the cells were treated for 72 h with kaempferol 
(12–100 µM) and 5-FU (1–10 µM), as the positive control, resulted in 
decrease of cell viability on time and concentration-dependent manner. 
Kaempferol also induced cellular apoptosis of HeLa cells through the 
upregulation and downregulation of genes such as p53, p21, casppase3, 
caspase9, Bax, and PTEN and PI3K, AKT, and Bcl-2, respectively [62].
Dehydrocostus lactone
Dehydrocostus lactone is a therapeutic plant derived sesquiterpene, 
which has been  extracted from Saussurea lappa [63] and 
Aucklandia lappa [64]. Dehydrocostus lactone has shown to possess 
antimycobacterial and antifungal activity [65], and it has been reported 
to induce apoptosis in different types of cancers such as lung cancer 
[66], breast cancer [67], and prostate cancer [68]. It has been studied 
that dehydrocostus lactone is used against hepatocellular cancer both 
by in vitro and in vivo methods, different in vitro methods are employed 
such as reverse transcriptase and PCR analysis, cell proliferation and 
clonogenic assay, caspase and apoptosis assay, immunoblot assay, and 
kinase activity assays, and by transmission electron microscopy, in vivo 
analysis on nude mice model was done. 16.7 and 18.8 µM were IC50 
values, and these results proved that this compound showed anticancer 
activity. In addition, tumor volume significantly reduced to 50% in the 
animal studies after 45 days of treatment [69]. Furthermore, activation 
of NF-kappa B (a transcription factor) is inhibited by this compound 
by preventing tumor necrosis factor (TNF)-alpha (apoptosis inducing 
factor) induced degradation and phosphorylation of the inhibitory 
protein I-kappa B alpha in HL-60 human leukemia (HL) cells, and by 
enhancing the activities of caspase-3 and caspase-8, dehydrocostus 
lactose provides susceptibility of HL-60 cells to TNF-alpha in which 
apoptosis is induced [70].
Quercetin
Quercetin (3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-
one) is an aglyconic flavonoid found in a wide range of food products 
of humans, including capers, lovage, berries, citrus fruits, red 
onions, cherries, grapes, apples, cherries, broccoli, and tea (Camellia 
sinensis) [71]. It has been recognized to have a variety of valuable 
effects on human health including antiviral, cardiovascular, anticancer, 
and anti-inflammatory actions [72]. In addition to this, also derivatives 
of quercetin played an important role in human health, which include 
anti-allergic, antiviral, antiulcer effects, cardiovascular protection, 
anticancer activity, and anti-inflammatory properties [73]. It has been 
observed that the quercetin treatment decreased the colony-forming 
ability and cell viability and also inhibited the proliferation of SCC-
25 cells through mitochondria-mediated apoptosis as well as through 
the cell cycle arrest at G1 phase in a dose-dependent manner. In the 
same manner, capabilities of invasion and migration of these cells also 
decreased by the treatment of quercetin. These results indicate that 
quercetin has great ability toward a new chemopreventive means and 
serves as additional remedial for oral squamous cell carcinoma [74].
It has been demonstrated that in a dose-dependent manner quercetin, 
repressed the viability of HeLa cervical cells by inducing mitochondrial 
Fig. 5: Homoharringtonin
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apoptosis through p53-dependent mechanism and also by cell cycle 
arrest at G2/M phase. This may result typical in mitochondrial 
membrane depolarization, nuclear morphology, modulation of cell 
cycle regulatory proteins and NF-κB family members, upregulation 
of pro-apoptotic Bcl-2 family proteins, caspases and cytochrome-C, 
and Apaf-1, and downregulation of antiapoptotic Bcl-2 proteins and 
surviving [75].
Rutin
Rutin also called quercetin-3-rutinoside with chemical formula is 
3,3′,4′,5,7 -pentahydroxyflavone-3-rhamnoglucoside and is a flavonol, 
which is found in large quantities in plants, such as Fagopyrum 
esculentum (buckwheat) [76], passion flower, apple, and tea, and it is 
a fundamental nutritional constituent of other food stuffs [77]. Rutin 
has numerous pharmacological properties, for example, anti-allergic, 
antioxidant, antiviral, anti-inflammatory, and anticarcinogenic [78]. 
Rutin is recognized to reduce the growth of cancer cell by apoptosis 
and/or by cell cycle arrest as well as inhibition of proliferation, 
metastasis, and angiogenesis in colorectal cell lines [79].
Anticancer activity of rutin has also been broadly studied in HL-60 cells, 
entrenched in a murine xenograft model which caused a major reduction 
in tumor size in the dose of 120 mg/kg, and this result suggests that 
rutin has a great antileukemic ability [80]. To find the toxicity of rutin 
and its defensive ability on hepatic cells, different essays have been used 
such as MTT assay, which showed toxicity at higher concentration of 
810 µM after 72 h of treatment where viability and proliferation of cells 
reduced, but it does not show any toxicity in different concentrations 
after 24 h of treatment, and the second is comet essay, which showed 
DNA damage significantly at highest concentration of 810 µM of rutin 
and was proved genotoxic to the hepatic (HTC) cells after 24 h of 
treatment [81]. It has been revealed that rutin retards neoplasia with 
azoxymethane through immunosuppression [82].
Curcumin
Curcumin (diferuloylmethane), a well-known flavonoids, having 
chemical formula 1,7-bis(4-hydroxy-3 methoxyphenyl)-1,6-
heptadiene-3,5-dione, has been isolated from the ground rhizome 
of the turmeric (Curcuma longa) [83]. For centuries, this naturally 
occurring phytochemical is used in a number of pharmaceutical 
applications [84]. Novel investigations divulge that curcumin and 
also the curcumin derivatives have diverse pharmacological activities 
including anti-inflammatory [85], antiviral [86], antimicrobial [87], free 
radical scavenging activity [88], and anticancer activity [89].
Its anticancer activity is refereed by its capability to adapt numerous 
pathways and target manifold genes, inflammatory cytokines, 
growth factors, transcription factors, adhesion molecules, enzymes, 
receptors, cell cycle proteins, and anti-apoptotic proteins which result 
in inhibition and apoptosis of migration and proliferation of cell [89]. 
Curcumin is found to be noxious to the cells which are cancerous 
and proved to be cytoprotective to healthy cells [90]. Predominantly, 
curcumin shows latent therapeutic and chemopreventive activities in 
a wide variety of cancers such as skin [91], breast [92], leukemia [93], 
lung [94], and hepatic [95]. It has been studied that curcumin inhibited 
fen1-dependent proliferation of breast (MCF-7) cancer cell in a dose-
dependent manner using MTT assay, in which Nrf2 protein expression 
is extensively induced resulted in the downregulation of Fen1 gene 
expression in a Nrf2-dependent manner. Advanced analysis revealed 
that curcumin might guide to translocation of Nrf2 from the cytoplasm 
to the nucleus and Fen1 promoter activity decreased by decreasing the 
function of Nrf2 to the Fen1 promoter. These records proposed that 
curcumin could inhibit the breast cancer cell proliferation through 
downregulation of Fen1 expression mediated by Nrf2 which might be 
a new method of tumor growth inhibition induced by curcumin [92].
Curcumin also restrained the activation of Wnt/β-catenin as well as 
Sonic Hedgehog pathways, which suggested that curcumin showed 
its interference consequences on lung cancer stem cells through the 
inhibition of these pathways, which provides new insights of curcumin 
that it has therapeutic application in the elimination of lung CSC and of 
cancer [94].
Ellagic acid
Ellagic acid having chemical formula 2,3,7,8-tetrahydroxy[1]-
benzopyrano[5,4,3-cde][1]benzopyran-5,10-dione) is a constituent of 
phenolic compounds in certain fruits and nuts, for example, strawberries, 
raspberries, walnuts, mango kernel, longan seed, and pomegranate, and 
it was recognized that ellagic acid possesses many pharmacological 
activities including metal chelating, antibacterial, antifibrotic, antiviral, 
radical scavenging, antiatherogenic, antimutagenic, and anticancer 
activities [96-98]. It has been found that ellagic acid induces cell cycle 
arrest at G1 phase of cell cycle with successive apoptosis in cervical 
cancer cells by G1 cyclin-dependent kinase inhibitor p21WAF1/CIP1 
activation [99]. It has also been observed that ellagic acid provoked the 
effects on colon adenocarcinoma cells (Caco-2 cells) by different ways 
such as cell-cycle arrest in S phase, downregulating of cyclins A and B1 
and upregulating of cyclin E, induction of apoptosis through intrinsic 
pathway (FAS-independent and caspase 8-independent) via bcl-XL 
down-regulation with mitochondrial release of cytochrome c into the 
cytosol, activation of initiator caspase 9 and effector caspase 3. Ellagic 
acid induced apoptosis in colon cancer cells through mitochondrial 
pathway without affecting the normal cells [100].
It has been observed that ellagic acid in higher doses is preventive against 
lung cancer, induced by tobacco carcinogen 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone, which was recognized to reduce the lung 
cytochrome P450 [101]. In vitro studies showed that ellagic acid also 
induced cell cycle arrest and apoptosis in human bladder (T24) cancer 
cells. To determine the cell viability, caspase-3 activity, apoptosis, and 
gene expression, different tests such as caspase-3 activity, polymerase 
chain reaction, and flow cytometric assay were performed. Results 
indicate that ellagic acid extensively decreased the viable cells, induced 
cell cycle arrest at G0/G1 phase, and apoptosis. Ellagic acid is also 
caused cell cycle arrest at G0/G1 phase of T24 cells, by increased p53 
and p21 and and reduced the CDK2 gene expression, and also the 
activity of caspase-3 is promoted to different time periods, which may 
lead to apoptosis induction [102].
Ergosterol peroxide
Ergosterol peroxide with chemical formula 5,8-epidioxy-22E-ergosta-6, 
22-dien-3-ol is isolated from the plant Naematoloma fasciculare in 
higher concentrations [103]. Ergosterol peroxide has a number of 
pharmacological activities such as antiviral [104], immunosuppressive 
[105], anti-inflammatory, and antitumor [106]. Ergosterol peroxide 
reduced the growth of HL60 cells and also induced apoptosis at the 
concentration of 25 µM after an incubation period of 24 h [107].
It has been suggested that ergosterol peroxide from Chaga mushroom 
(Inonotus obliquus) downregulated β-catenin signalling and resulted in 
reduced transcription of cMyc, cyclin D1, and CDK-8, which exerted pro-
apoptotic and antiproliferative activities in CRC cells. This compound 
suppressed CRC cell lines proliferation and inhibited colitis-associated 
colon cancer in AOM/DSS-treated mice efficiently [108]. Aqueous 
extract of Chaga mushroom has been reported to prevent intestinal 
inflammation and CRC chemical-induced mice models by regulating 
NF-κB and Wnt/β-catenin signalling [109,110]. These observations 
indicate that Chaga mushroom extract contains ergosterol peroxide as 
a great role in preventing CRC (Table 2).
SOME PLANTS WITH ANTICANCER ACTIVITY
A wide range of herbal plants with therapeutic values is being used 
against cancer, and some important areas are as follows:
Allium sativum
A. sativum, the medicinal prosperity of Allium vegetables, especially 
garlic (A. sativum), has been recognized throughout the written 
history [118]. It has been used for curing of a number of diseases 
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Table 2: Some plant‑based anticancer agents and their effects on cancer type
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such as cancer, cardiovascular disorders, HIV drug-induced lipid 
disorders, cold, flu, and prevention of tick bite, which appear to act 
efficiently against erythro-leukemic disorders as well as breast and 
prostate cancer cells [119,120]. The anticancer activity of garlic is 
due to the presence of a number compounds, and among them, two 
major groups have been identified as effective against cancer, one 
group contains lipid-soluble allyl sulfur compounds which include 
diallyl disulfide and diallyl trisulfide, and the other group contains 
water-soluble γ-glutamyl S-allylcysteine (SAC) compounds such as SAC 
and S-allyl mercaptocysteine [121]. Several mechanisms of garlic and 
their organosulfur compounds explained the preventive measures of 
cancer, and these include free radical scavenging property, inhibition of 
mutagenesis, modulation of enzyme activities, reduction of DNA adduct 
formation, and effects on cell proliferation and tumor growth [122].
It has also been reported that WEHI-164 tumor cells were injected in a 
pre-clinical BALB/c mice model and then divided into six groups. The 
boiled garlic extracts at 20 mg/kg/0.2 mL were given to the treatment 
group. After 3 weeks, the results showed that the tumor size of garlic 
extract-treated groups was reduced significantly as compared to the 
control group [123].
Annona muricata L
A. muricata L. (Annonaceae family) is commonly known as soursop, 
graviola, guanabana, paw-paw, and sirsak. Previously, it has been 
demonstrated that the leaves of A. muricata showed significant 
cytotoxicity against several cancer cell lines without disturbing the 
normal cells [124,125]. The constituents isolated from A. muricata 
leaves are Annonaceous acetogenins, alkaloids, and essential oils. Among 
them, A. acetogenins are powerfully understood to be dependable for the 
promising anticancer effect [126]. Recently, in vitro methods determine 
the mechanism of action of ethyl acetate extract of A. muricata leaves 
against colon cancer cells (HT-29 and HCT-116) and lung cancer cells 
(A549) by the induction of apoptosis in these cell lines through the 
mitochondrial-mediated pathway. This shows antiproliferative effect, 
associated with cell cycle arrest in the G1 phase [127]. Due to the 
remarkable antiproliferative effect, A. muricata was expressed as “the 
cancer killer [125].”
It has also been recommended that ethanolic extract of A. muricata 
leaves has apoptosis-inducing potential against myelogenous leukemic 
K562 cells. This was confirmed by TUNEL assay [128]. Recent studies 
by in vitro and in vivo methods of the water extract of A. muricata leaves 
were performed against the benign prostatic hyperplasia (BPH-1) cell 
line and rat’s prostates, and it showed the repressive effect on BPH-
1 cells with an upregulation of Bax and a downregulation of Bcl-2 at 
the mRNA level having IC50 value of 1.36 mg/mL after 72 h associated. 
The size of the rats’ prostates was decreased, after 60 days of treatment 
with the extract in the concentration. of 30 and 300 mg/mL doses, 
which was indicated to appear through induction of apoptosis [129].
Not only in vitro but also in vivo investigations are limited to anticancer 
examination of A. muricata. A reported case study of 66-year-old 
woman having metastatic breast cancer resulted in the stabilization 
of this disease by the consumption of the leaves boiled in water and 
Xeloda [130].
C. sinensis
C. sinensis (L.), family Theaceae, is commonly known as “Tea” which 
is most accomplished drink in the world. Chinese tea is produced 
from the leaves and leaf buds of this plant species. Instead, many 
teas such as green tea, white tea, black tea, and oolong tea are also 
collected from this plant, but they are processed in different ways 
according to their oxidation levels [131]. It has been reported that 
teas contain nearly 4000 bioactive compounds, one-third of which 
is contributed by polyphenols [132], which are mostly flavonoids 
[133]. Among polyphenols, catechins such as (-)-epicatechin gallate 
(ECG), (-)-epicatechin (EC), (-)- epigallocatechin (EGC), and (-)-
EGC gallate (EGCG) are thought to be responsible for health benefits 
that have conventionally been recognized to tea particularly green 
tea. (-)-EGCG of green tea is most effective catechin and obtained in 
higher concentration as compared to black tea [134,135]. It has been 
confirmed that green tea has the efficiency to cure skin cancer caused 
by ultraviolet radiation [136].
Catechins from green tea have reputed anticancer properties in the 
tumor cell proliferation inhibition, and also, they help in the devastation 
of leukemia cells [137]. Epidemiologically, it has been shown that EGCG, 
a potent polyphenol in green tea, has been seen to play a crucial role on 
invasion inhibition and migration of human oral and colon cancer cells 
which can be linked with the reduced production of MMP-2, MMP-9, and 
uPA. It has also been found that EGCG inhibits the growth of carcinoma 
of ovarian cell lines OVCA and HEY, human colon, and rectal cancer cell 
lines HT-29 and HCA-7 [138,139].
Momordica charantia
This plant is from family Cucurbitaceae, popularly known as bitter gourd, 
bitter apple, bitter melon, Karela, balsam pear, and wild cucumber. In 
stern and Southern Asia, it is an essential market vegetable [140] and 
is extensively cultivated in Asia, Africa, and South America [141]. It has 
been reported that the crude extracts of fruit and leaf of M. charantia 
have antitumor capability on some tumors, which include prostate 
cancer [142], melanoma and DMBA-induced skin tumorigenesis, and 
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CRC: Colorectal cancer, V. grandiflorum: Veratrum grandiflorum, V. vinifera: Vitis vinifera, C. sinensis: Camellia sinensis, C. spinosa: Capparis spinosa, S. lappa: Saussurea 
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cytogenicity [143], and also antitumor activity in murine lymphoma was 
reported approximately two decades back [144]. MAP30 (Momordica 
protein of 30 kDa) is one of various ribosome-inactivating proteins (RIPs) 
from M. charantia showed anti-tumor activity, and its effectiveness has 
been tested in estrogen-independent and highly metastatic human breast 
tumor MDA-MB-231 cells, resulted in the inhibition of in vitro expression 
of the HER2 gene plus inhibition of tumor cell proliferation [145].
Particularly, the extract of M. charantia using methanol as solvent 
revealed cytotoxic consequence against a variety of cancer cell lines such 
as HCT-116 colorectal, hone-1 nasopharyngeal carcinoma, AGS gastric 
adenocarcinoma, and CL1-0 lung adenocarcinoma cells with IC50 value 
ranging from 0.25 to 0.35 mg/mL [146]. Besides, a cucurbitane-type 
triterpene screened from wild bitter gourd provoked apoptotic death 
in breast cancer cells through the activation of peroxisome proliferator-
activated receptor γ [147].
W. somnifera
A shrub of Solanacea family regarded as one of the important members 
of generally regarded as safe plants found all over in India [148], having 
anticarcinogenic properties [149]. It has been suggested that this plant 
is used as an alternative long-term remedy to avoid the spread of cancer 
cells, after the analysis of root extracts against vimentin pro-metastatic 
protein, and thus, this plant is used to create motility inhibition of cells 
of breast tumors in different formulations [150].
Formerly, the extract from the roots of W. somnifera was used to treat 
many ailments such as rheumatism, arthritis, and hypertension in 
traditional Indian medicine [148], but presently, in the United States, 
the same extract is used as a dietary enhancement and has received 
universal attention due to its pharmacological actions [151]. Essential 
phytochemicals of W. somnifera are withanolides, withaferin, and 
derivatives [152]. WA, a steroidal lactone, isolated from the extracts 
of this plant showed significant antitumor efficiency in vivo [151]. It 
has been proved that even in small concentrations, the root extracts 
of W. somnifera can inhibit the breast cancer metastasis with nominal 
adverse effects in rats [150]. Similarly, it has also been described 
that W. somnifera was used against prostate tumors by the metabolic 
inactivation of CDC2 catastrophe followed by cell death, by acting as a 
phase G2/M cell cycle of tumor cells [153].
The study reveals that the active component of aqueous leaf extract 
such as triethylene glycol shows accountable anticancer activity by the 
activation of p53 and pRB (tumor suppressor protein) by preparing the 
hydroalcoholic leaf extract to evaluate the cytotoxicity against breast 
cancer, lung cancer, and ovary cancer [154], this suggests that the leaf 
extracts are more effective for breast cancer compared to lung and 
ovary cancer, and this hydroalcoholic leaf extract contains polyphenolic 
compound which is more effective against cancer cells.
C. sativus
C. sativus L.(saffron) is an important member of family Iridaceae, 
which among the various spices has been created an interest, because 
in addition to flavoring means, it has been used in a large number 
of properties including antimutagenic, free radical scavenging, and 
immunomodulating effects, after a number of pharmacological 
experiments [155]. By the ancient Chinese, Arabian, and Indian 
cultures, saffron is used as an herbal remedy for a variety of disorders 
including cancer [156]. Saffron is rich in carotenoids, which include two 
major natural carotenoids, crocin and crocetin, which are responsible 
for its color. After the pre-clinical evidences, it has been revealed that 
the dietary intake of saffron and its ingredients affects antitumor 
property through in vitro and in vivo methods [157]. It has the potential 
to induce apoptotic and cytotoxic effects in A549 (lung cancer cells), 
and following saffron administration, cell proliferation reduced by 
giving it in a time- and dose-dependent way [158].
It has been investigated that the antiproliferative activities of extracts 
obtained from saffron and its chemical constituent “crocin” against 
5 different malignant and also non-malignant prostate cancer cell 
lines, by which all these cells were incubated for 48 h in different 
concentrations of saffron extract and crocin. It has been observed that 
both saffron extract and crocin reduced proliferation of these malignant 
cell lines having IC50 values for saffron extract ranging between 0.4 and 
4 mg/mL, and for crocin, it may range from 0.26 to 0.95 mM/mL, in a 
time- and concentration-dependent way, but there is no change in non-
malignant cells. By the presence of the most of the apoptotic cells, flow 
cytometry analysis revealed that majority of cells were arrested at G0/
G1 phase. It has been studied that after the analysis of western blot, Bcl-
expression was strikingly downregulated, while Bax was upregulated. 
These findings suggest that both saffron extract and crocin inhibit cell 
proliferation, inducing apoptosis, and arrest cell cycle progression 
and act as a chemotherapeutic as well as chemopreventive agent for 
prostate cancer management [159].
It has also been reported by other researchers that the saffron extract 
and crocin extensively repressed the growth of CRC cells, while normal 
cells were not affected [160]. To find the effect of crocetin on cancer 
cells of breast, the MDA-MB-231 cells which are highly persistent were 
used, and their viability and persistence were measured with the WST-
1 assay and a reconstituted basement membrane, respectively. Results 
show that invasiveness of MDA-MB-231 cell inhibited through crocetin 
through down regulation of MMP expression [161]. Recent studies 
showed that crocetin has major potential as an antitumor agent in cell 
cultures and animal model systems by inducing apoptosis, enhancing 
anti-oxidative system, affecting the growth of cancer cells (by inhibiting 
nucleic acid synthesis), and hindering growth factor signaling 
pathways [156].
C. longa
C. longa L. a perennial herb, from the family Zingiberaceae, measures 
up to 1m height having a short stem, which is being widely cultivated in 
Asian countries, mostly in India and China and is distributed throughout 
tropical and subtropical regions of the world [162]. In addition to 
cholesterol-lowering, anti-inflammatory, antidiabetic, and antioxidant 
properties, curcumin has said to have anticancer activity in both in vitro 
and in vivo models. Clinical studies on humans showed that curcumin is 
safe and effective. It has been confirmed by the FDA that this compound 
curcumin is generally recognized as safe [163,164].
It has been studied that these methods (in vitro and in vivo) designate 
that curcumin avoids carcinogenesis by disturbing two main processes 
such as tumor growth and angiogenesis [165]. It has been confirmed 
that administration of curcumin extensively reduces the levels of 
CDK4 and cylin D1 (cell cycle regulators), and expression of p53 was 
inhibited, in which p53 is an upstream controller of the CDK4-cylin D1 
complex [166]. It provokes cell death in a number of animal and human 
cell lines including melanoma, leukemia, and carcinoma of ovaries, lungs, 
liver, colon and breast [167]. Cell growth of Chinese Hamster Ovary cell 
is inhibited by the extracts obtained from C. longa at a concentration of 
0.4 mg/mL, and in the same concentration, it was proved to be cytotoxic 
against Dalton’s lymphoma cells and lymphocytes. The cytotoxic effect 
was seen at room temperature (30°C) within half an hour. Curcumin, 
the active constituent of C. longa also showed cytotoxic effects against 
Dalton’s lymphoma cells and lymphocytes at a concentration of 4μg/
mL. Initial trials signified that C. longa extract and curcumin diminished 
the growth of animal tumours [168].
Achyranthes aspera
A. aspera L., from the family Amaranthaceae, is a small herb with a number 
of medicinal properties, against dysentery, rheumatism, bronchitis, 
malarial fever, renal and cardiac dropsy, asthma, hypertension, cough 
and diabetes mellitus, found throughout India [169]. In addition to this, 
Indian Ayurvedic medical practitioners have used this herb, especially 
the leaves and roots as a therapeutical agentsfor cancer therapy [170]. 
This plant alone or in amalgamation has played a very crucial role 
to cure pancreatic cancer as well as tumors of other organal sites. 
Undependable reports indicate that the plant extract recovered the 
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whole general welfare in cancer patients, especially those suffering 
from cancer of pancreas, when the extract is administered orally. It has 
been demonstrated that the leaf extract of this plant obtained using 
methanol as solvent system showed cellular specificity, and time- and 
dose-dependent cytotoxicity to the cancer cells of humans in vitro 
without harming the normal cells [171].
It has been reported that the alkaloid, non-alkaloid, and saponin 
fractions obtained from methanolic extract showed cancer prevention 
induced by the carcinogen 12-O-tetradecanoylphorbol-13-acetate (at a 
concentration of 100 µg) on the Epstein–Barr virus early antigen in Raji 
cells. The non-alkaloid fractions having polar compounds showed the 
most significant inhibitory activity in vitro [172].
Oroxylum indicum
O. indicum (also called Sonapatha) from the family Bignoniaceae is 
found to be an important herb in Ayurvedic medicine, in which all of 
its parts showed indigenous medicinal properties [173]. Using various 
in vivo and in vitro models, studies have proved a number of anticancer 
probabilities of O. indicum. It has been reported that the extraction 
of O. indicum with ethanol in the concentration of 0.05% showed 
antiproliferative and cytotoxic effects against Hep 2 cell lines [174].
It has been reported that the methanolic fruit extract of this plant also 
caused in vitro proliferation of HL-60 cell lines and the most important 
and active chemical constituent baicalein (a flavonoid) isolated from 
this extract, provoked apoptosis of tumor cells in advanced doses, and 
showed more cytotoxicity against HL-60 cell lines. After treating with 
baicalein, the cell viability was quantified using trypan blue staining 
after 24 h, and the results indicate that this compound caused 50% 
inhibition of HL-60 cell lines at 25–30 µM concentration [175].
Some researchers reported that the extract obtained from this 
plant using the same solvent system powerfully reduced the Trp-P-1 
mutagenicity in an Ames test. It happened due to the presence of 
baicalein (3.95±0.43%, dry weight) in the methanolic extract having the 
IC50 value of 2.78±0.15 µM and it acted as desmutagen as it repressed 
the Trp-P-2 N-hydroxylation [176]. It has been found genotypic and 
showed cell proliferative activity after the administration of a crude 
extract of O. indicum in the concentration of 0.25–2 g/kg of body weight 
of the pyloric mucosa of the stomach of rat [177]. In addition, the extract 
obtained from O. indicum using ethanol as solvent showed strong 
toxicity on many tumor cell lines such as B-16, HL-60, CEM, and HCT-8 
having IC50 values 17.2, 14.2, 19.6, and 32.5l g/mL, respectively [178].
Recently, it has been confirmed that O. indicum extracts such as 
methanolic and aqueous extracts revealed extensive cytotoxicity in 
certain cell lines having restrained levels of DNA protection from 
oxidative stress [179].
CONCLUSION
The American Cancer Society defines cancer as a group of diseases that 
are characterized by the uncontrolled growth and spread of abnormal 
cells. Normal cells divide rapidly to supply the new growth necessary to 
replace injured cells and then return to normal rate of division. Cancer 
cells divide haphazardly and accumulate into a non-structured mass 
or tumor. The tumor becomes invasive when they spread beyond their 
point of origin, and even after spreading, they continue to behave like 
cancer at the original site. All our cells share a majority of functions 
and are similar in structure. Cancers can be classified by function 
and location of the cells from which they originate. The cancer can be 
classified as per their derivation, like carcinomas, which are derived 
from epithelial tissues, leukemias which originate from white blood 
cells, and myeloma which is the cancer of white blood cells that are 
responsible for the manufacture of antibodies.
According to the WHO, approximately 80% population from developing 
countries are facing complications from synthetic drugs. There are 
various methods for treatment of cancer. Surgery is typical and first 
choice and is done when cancer is localized meaning it has not spread. 
The next method is chemotherapy which is used depending on the type 
and stage of cancer. The chemotherapeutic strategies are very striking 
and have earned serious concern as potential means of controlling 
the incidence of this dreadful disease. Chemotherapy especially treats 
cancer by injecting strong medicine to a patient and allowing the drugs 
to travel throughout the body. The treatment is given in cycles. The side 
effects include vomiting, hair loss, infections, and fatigue. Radiation also 
treats localized cancer. It destroys cancer cells, so they do not multiply. 
It is used alone or in addition to chemotherapy. More than one half 
people undergo radiation.
Although a great advancement has been made in treatment and control 
of cancer progression. A number of undesired side effects sometimes 
occur during chemotherapy. Since ancient times, medicinal plants have 
attracted enormous attention to fight against various diseases due to 
their broad-spectrum biological and therapeutic properties. The use of 
medicinal plant products to menage or arrest the carcinogenic provides 
an alternative to use the conventional allopathic medicine for treatment 
of the disease. Many herbs with diverse chemical structures of natural 
origin from plants have been discovered as anticancer agents, such 
as VCR, VLB, podophyllotoxin, CPT, taxol, resveratrol, WA, quercetin, 
and curcumin. These plant-derived products have shown promise 
anticancer therapies. There are evidences that these plant products 
have shown relatively low side effects, and more research on plants 
and plant-derived chemicals may result in the discovery of potent 
anticancer agents. We aim to investigate the selected medicinal plants 
for their anticancer properties. In particular, novel compounds from 
plants have beneficial effects on human health.
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